US2020397831A1PendingUtilityA1
Use of akkermansia in the treatment of oral diseases
Est. expiryDec 21, 2038(~12.4 yrs left)· nominal 20-yr term from priority
A61K 9/0014A61Q 11/00A61K 35/74A61K 35/741A61P 1/02A61K 9/0053
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the use of Akkermansia and/or fragments thereof in the treatment and/or prevention of oral diseases. In particular, the present invention relates to Akkermansia muciniphila and/or fragments thereof, such as proteins and secreted molecules, for use in treating and/or preventing oral diseases.
Claims
exact text as granted — not AI-modified1 . Akkermansia and/or fragments thereof for use in the treatment of oral diseases.
2 . Akkermansia and/or fragments thereof for use according to claim 1 , wherein said oral diseases are selected from the group comprising or consisting of periodontal diseases, periodontitis, gingivitis, peri-implant mucositis, peri-implantitis, oral thrush, dental caries and black hairy tongue.
3 . Akkermansia and/or fragments thereof for preventing and/or improving bad breath in a subject in need thereof.
4 . Akkermansia and/or fragments thereof for use according anyone of claims 1 to 3 , wherein said Akkermansia is selected from the group comprising or consisting of Akkermansia muciniphila, Akkermansia glycaniphilus and variants thereof.
5 . Akkermansia and/or fragments thereof for use according to anyone of claims 1 to 4 , wherein said Akkermansia is alive.
6 . Akkermansia and/or fragments thereof for use according to anyone of claims 1 to 4 , wherein said Akkermansia is pasteurized.
7 . Akkermansia and/or fragments thereof for use according to any one of claims 1 to 6 , wherein said fragments are selected from the group comprising or consisting of the protein Amuc_1100 and Akkermansia -derived extracellular vesicles.
8 . Akkermansia and/or fragments thereof for use according to any one of claims 1 to 7 , wherein said Akkermansia and/or fragments thereof is orally administered.
9 . Akkermansia and/or fragments thereof for use according to claim 8 , wherein said oral administration comprises oral administration and topical administration.
10 . A composition for treating oral diseases or for preventing and/or improving bad breath comprising Akkermansia and/or fragments thereof in association with an excipient.
11 . A pharmaceutical composition comprising Akkermansia and/or fragments thereof and at least one pharmaceutically acceptable excipient for treating oral diseases.
12 . A medicament comprising Akkermansia and/or fragments thereof for treating oral diseases.
13 . A medical device comprising Akkermansia and/or fragments thereof for treating oral diseases.
14 . Use of Akkermansia and/or fragments thereof for preventing and/or improving bad breath in a subject in need thereof.
15 . A cosmetic composition comprising Akkermansia and/or fragments thereof for preventing and/or improving bad breath.Join the waitlist — get patent alerts
Track US2020397831A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.